[144] Edwards Lifesciences Corp SEC Filing

Rhea-AI Filing Summary

EW reported an insider sale notice for Common stock showing 24,000 shares listed to be sold on 02/25/2026 via Morgan Stanley Smith Barney LLC in connection with an exercise of options under a registered plan for cash.

The excerpt also lists prior sales by BOBO JR FAMILY TRUST on 12/10/2025 and 12/12/2025 with quantities 11,340, 5,900, and 5,486 respectively.

Insights

Corporate Governance & Compliance Specialist

Form 144 lists a planned sale of 24,000 common shares tied to option exercise.

The filing shows 24,000 shares to be sold on 02/25/2026 through Morgan Stanley Smith Barney LLC, arising from an exercise of options under a registered plan. The transaction is described as for cash.

Previous dispositions by BOBO JR FAMILY TRUST are listed with dated sale quantities of 11,340, 5,900, and 5,486; these appear as historical activity in the excerpt. Timing and final settlement details are limited to the dates shown.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	24000	2012076.00	580300000	02/25/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/25/2026	Exercise of options under a registered plan	Issuer			24000	02/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BOBO JR FAMILY TRUST ONE EDWARDS WAY IRVINE CA 92614	Common	12/12/2025	5900	494066.00
Bobo Jr Family Trust ONE EDWARDS WAY IRVINE CA 92614	common	12/12/2025	5486	459682.00
Bobo Jr Family Trust ONE EDWARDS WAY IRVINE CA 92614	common	12/10/2025	11340	950581.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)